Expression of Telomeric Repeat Binding Factor 1 Protein in Nonsmall Cell Lung Cancer With Human Telomerase Reverse Transcriptase Positive

Abstract

Telomeric repeat binding factor 1 plays pivotal roles in telomere protection and maintenance in mammalian cells. In this article, the expression of telomeric repeat binding factor 1 protein in nonsmall cell lung cancer with human telomerase reverse transcriptase positive is investigated, and the relationship between the telomeric repeat binding factor 1 and clinic factors is analyzed. The expressions of human telomerase reverse transcriptase were detected by immunohistochemistry. The levels of telomeric repeat binding factor 1 protein were measured by Western blot. In all, 72% (36/50) patients showed human telomerase reverse transcriptase positive. Telomeric repeat binding factor 1 expression of cancer tissues and paired noncancerous tissues in 30 cases of human telomerase reverse transcriptase positive was 0.552 ± 0.329 and 0.654 ± 0.476, respectively (P < .05). No significant difference in telomeric repeat binding factor 1 protein expression was observed among sex, clinical stages, pathological subtypes, and lymph node metastasis. The results indicated that down-regulation of telomeric repeat binding factor 1 expression appeared in lung cancer tissue, and no correlation was found between telomeric repeat binding factor 1 expression and clinicopathologic factors.

Keywords

nonsmall cell lung cancer telomeric repeat binding factor 1 telomerase reverse transcriptase immunohistochemistry Western blot

Get full access to this article

View all access options for this article.

References

van Steensel B. , de Lange T. Control of telomere length by the human telomeric protein TRF1. Nature. 1997; 385:740-743.

Wu XF , Amos CI , Zhu Y. , et al. Telomere dysfunction: a potential cancer predisposition factor . J Natl Cancer Inst. 2003;95:1211-1218.

Yamada K. , Yajima T. , Yagihashi A. , et al. Role of human telomerase reverse transcriptase and telomeric-repeat binding factor proteins 1 and 2 in human hematopoietic cells. Jpn J Cancer Res. 2000;91:1278-1284.

Bianchi A. , Smith S. , Chong L. , Elias P. , de Lange T. TRF1 is a dimer and bends telomeric DNA. EMBO J. 1997; 16:1785-1794.

Lin X. , Gu J. , Lu C. , Wu X. Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer. Clin Cancer Res. 2006;12:5720-5725.

Ancelin K. , Brunori M. , Bauwens S. , et al. Targeting assay to study the cis functions of human telomeric proteins: evidence for inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2. Mol Cell Biol. 2002;22:3474-3487.

Wang Z. , Kyo S. , Takakura M. , et al. Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway. Cancer Res. 2000;60: 5376-5381.

Wang W. , Luo HS , Yu BP Expression of NF-kB and human telomerase reverse transcriptase in gastric cancer and precancerous lesions. World J Gastroenterol. 2004;10: 177-181.

Hu J. , Sun L. , Zhang C. , Xielai Z. Expression of telomeric repeat binding factor 1 in non-small cell lung cancer . J Surg Oncol. 2005;93:62-67.

10.

Antonio M. , Gloria B. , Fiamma B. , et al. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer. Clin Cancer Res. 1999;5:2077-2081.

11.

Lan JP , La XY , Zhu YY , et al. Localization of human telomere repeat binding factor 1 in telomerase-positive and-negative cells and its expression during cell cycle. J Zhejiang Univ. 2004;33:475-480.

12.

Hsu CP , Ko JL , Shai SE , Lee LW Modulation of telomere shelterin by TFR1 and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer. Lung Cancer. 2007;58: 310-316.

13.

Hsu CP , Miaw J. , Shai SE , Chen CY Correlation between telomerase expression and terminal restriction fragment length ratio in non-small cell lung cancer-an adjusted measurement and its clinical significance. Eur J Cardiothorac Surg. 2004;26:425-431.

14.

Miyachi K. , Fujita M. , Tanaka N. , Sasaki K. , Sunagawa M. Correlation between telomerase activity and telomeric-repeat binding factors in gastric cancer. J Exp Clin Cancer Res. 2002;21:269-275.

15.

Yamada K. , Yagihashi A. , Yamada M. , et al. Decreased gene expression for telomeric-repeat binding factors and TIN2 in malignant hematopoietic cells. Anticancer Res . 2002;22:1315-1320.

16.

Yamada M. , Tsuji N. , Nakamura M. , et al. Down-regulation of TRF1, TRF2 and TIN2 genes is important to maintain telomeric DNA for gastric cancers. Anticancer Res . 2002;22:3303-3307.

17.

Oh BK , Kim YJ , Park C. , Park YN Up-regulation of telomere-binding proteins, TRF1, TRF2, and TIN2 is related to telomere shortening during human multistep hepatocarcinogenesis. Am J Pathol. 2005; 166:73-80.

18.

Nakanishi K. , Kawai T. , Kumaki F. , et al. Expression of mRNAs for telomeric repeat binding factor (TRF)-1 and TRF2 in atypical adenomatous hyperplasia and adenocarcinoma of the lung. Clin Cancer Res. 2003; 9:1105-1111.